The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Prospects for Treating Patients with Arthritis in African Countries with Few Rheumatologists

Prospects for Treating Patients with Arthritis in African Countries with Few Rheumatologists

June 14, 2017 • By Elizabeth Hofheinz, MPH, MEd

  • Tweet
  • Email
Print-Friendly Version / Save PDF

When it comes to medications, balancing cost and clinical effectiveness is always a huge challenge. “Biologics are not an option for the vast majority of African patients. Not only are they expensive, but they require refrigeration, which is not always a given. Using triple therapy for the treatment of rheumatoid arthritis (e.g., methotrexate, sulfasalazine and hydroxychloroquine) does treat rheumatoid arthritis well. And while it is a much less expensive option than a biologic, the ability to monitor for toxicity is a barrier.

You Might Also Like
  • Rheumatologists Treating Patients with HIV Face Treatment, Diagnostic Challenges
  • Experts Discuss Rheumatologists’ Role in Treating Depression, Anxiety and Psychological Comorbidities in Their Patients
  • Demand for Arthritis Care in America Outstrips Supply of Practicing Rheumatologists
Explore This Issue
June 2017
Also By This Author
  • New Studies Examine Impact of Poverty, Race, Ethnicity in Patients with SLE

“Some of my colleagues in Ethiopia are trying to introduce an arrangement [in which] hospitals could negotiate with labs that monitor for methotrexate toxicity and then have a package deal that includes lab tests so that monitoring is less expensive and uniform. But there is always the ethical question: ‘Do you start someone on a medication they need if you may not be able to monitor them adequately and/or continue the medication?’”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Meltzer is in the startup phase of her new initiative, called Rheumatology for All, a 501c whose goal is to educate rheumatologists in underserved areas—starting with Ethiopia and Kenya. “We are currently raising funds and have established that training will cost roughly $20,000 per person. As for locations, we are looking at McGill University, the University of Toronto or the University of KwaZulu-Natal in Durban, South Africa.”

“In any resource-poor area, noncommunicable diseases are given a lower priority. We have to shift the thinking of those who lead these countries. … We have to get them to see that, for example, an infection is short lasting, while a chronic or immune disease left untreated can lead to premature death and cause disability for a lifetime.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The pain and suffering caused by arthritis in Africa seems incalculable. And yet, calculate it is what we must do.

Dr. Meltzer closes with these words of wisdom, echoed by her dedicated colleagues: “We need epidemiological studies on the impact of rheumatic diseases. That way we can approach the governmental decisionmakers with hard, indisputable facts that cannot be ignored.”


Elizabeth Hofheinz, MPH, MEd, is a freelance medical editor and writer based in the Greater New Orleans area.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. The American College of Rheumatology. 2015 workforce study of rheumatology specialists in the United States.
  2. Meltzer M. Oral communication. 2017 Apr.
  3. Mody G. Oral communication. 2017 Apr.
  4. United Nations, Department of Economic and Social Affairs, Population Division. World population prospects: The 2015 revision. Key findings and advance tables.
  5. Mody GM. Rheumatology in Africa—challenges and opportunities. Arthritis Res Ther. 2017 Mar 7;19(1):49.
  6. Meltzer M, Price A. Bioethical challenges to rheumatology in resource poor areas: A review. African Journal of Rheumatology. 2017;5(1).

In Brief

Four seasoned rheumatologists share their thoughts on the prospects for treating arthritis patients in Africa, where there are too many patients, not enough doctors & a pool of meager resources that has to be shared.

Pages: 1 2 3 4 5 6 7 | Single Page

Filed Under: Conditions, Education & Training, Practice Management, Workforce Tagged With: Africa, Arthritis, Ethiopia, Nigeria, patient care, Rheumatic Disease, rheumatologist, shortage, TreatmentIssue: June 2017

You Might Also Like:
  • Rheumatologists Treating Patients with HIV Face Treatment, Diagnostic Challenges
  • Experts Discuss Rheumatologists’ Role in Treating Depression, Anxiety and Psychological Comorbidities in Their Patients
  • Demand for Arthritis Care in America Outstrips Supply of Practicing Rheumatologists
  • Rheumatologists May Help Patients with Rheumatoid Arthritis Overcome Obstacles to Sex

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)